NAL Pharmaceuticals Ltd. - Product Pipeline Analysis, 2013 Update - New Market Report
NAL Pharmaceuticals Ltd. (NAL Pharma) is a drug development company. The company develops drug and proprietary drug delivery systems (DDS) in the US and China. Its captive DDS technologies include Bio-FX fast-onset oral cavity DDS, Bio-D3 target delivery transdermal DDS, Bio-CR controlled-release oral DDS and bio-MM macromolecular DDS. NAL Pharma provides central nervous system, oncology, arthritic and acute pain, smoking cessation, cardiovascular, allergy and respiratory products. Its therapeutic areas consist of chronic severe pain, breakthrough pain, arthritic pain, migraine, asthma,...
View full press release